Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00682_DB06268> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00682_DB06268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00682_DB06268 label "DDI between Warfarin and Sitaxentan - Sitaxentan, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Warfarin doses should be decreased by 80% upon initiated of concomitant therapy. Monitor for changes in the therapeutic and adverse effects of warfarin if sitaxentan is initiated, discontinued or dose changed. [drugbank_resource:DB00682_DB06268]" assertion.
- drugbank_resource:DB00682_DB06268 identifier "drugbank_resource:DB00682_DB06268" assertion.
- drugbank_resource:DB00682_DB06268 title "DDI between Warfarin and Sitaxentan - Sitaxentan, a strong CYP2C9 inhibitor, may decrease the metabolism of warfarin. Warfarin doses should be decreased by 80% upon initiated of concomitant therapy. Monitor for changes in the therapeutic and adverse effects of warfarin if sitaxentan is initiated, discontinued or dose changed." assertion.